New drug that alters skeletal muscle metabolism - a β2 agonist. https://www.sciencedaily.com/releases/2026/06/260603015541.htm

Early days, but it might be of use (off label) for the subset of MECFS patients with high adrenergic autoantibody levels.

Maybe immunoabsorption to remove auto antibodies, then a course of this new drug?

#mecfs #longcovid #pais